Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
芪红胶囊
- Development stage
- Phase 2
- Lead developer
- Humanwell Healthcare
- Administration
- Oral
01
Overview
**芪红胶囊** is an oral multi-herb traditional Chinese medicine capsule under development for chronic heart failure with the traditional Chinese medicine syndrome classification of qi deficiency and blood stasis. It has been studied as an add-on to standard heart-failure treatment; a randomized controlled clinical study reported outcomes comparable with Qiliqiangxin Capsule over 12 weeks, without observed adverse events in the analyzed cohort. Its therapeutic rationale is based on traditional actions described as supplementing qi, promoting blood circulation, warming yang, and reducing fluid retention, rather than a clinically established single molecular target. ([cjim.cn](https://www.cjim.cn/zxyjhcn/zxyjhcn/ch/reader/view_abstract.aspx?file_no=2023091056&flag=1&journal_id=zxyjhcn))
- Other names
- Qihong Capsule
Beyond the preview
Go deeper on 芪红胶囊.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 芪红胶囊.